Immunomodulators as an antimicrobial tool

Liise anne Pirofski, Arturo Casadevall

Research output: Contribution to journalArticle

Abstract

The spectrum of infectious diseases has shifted in the past 50 years to include those caused by microbes that cause disease predominantly in immunocompromised individuals. This phenomenon has underscored the dependence of microbial virulence on the immune status of the host. The limited efficacy of the available antimicrobial armamentarium in immunocompromised individuals, combined with increasing resistance to these agents, has led to an urgent need for new therapies for infectious diseases. Immunomodulation represents a novel approach to antimicrobial therapy that depends on bolstering host immunity, rather than direct antimicrobial activity. Immunomodulators can be divided into those that are specific to pathogens (pathogen-specific) and those that are not specific to pathogens (non-specific). However, to date only a few immunomodulators have been evaluated for their efficacy as antimicrobial tools.

Original languageEnglish (US)
Pages (from-to)489-495
Number of pages7
JournalCurrent Opinion in Microbiology
Volume9
Issue number5
DOIs
StatePublished - Oct 2006
Externally publishedYes

Fingerprint

Immunologic Factors
Communicable Diseases
Immunomodulation
Virulence
Immunity
Therapeutics

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology

Cite this

Immunomodulators as an antimicrobial tool. / Pirofski, Liise anne; Casadevall, Arturo.

In: Current Opinion in Microbiology, Vol. 9, No. 5, 10.2006, p. 489-495.

Research output: Contribution to journalArticle

Pirofski, Liise anne ; Casadevall, Arturo. / Immunomodulators as an antimicrobial tool. In: Current Opinion in Microbiology. 2006 ; Vol. 9, No. 5. pp. 489-495.
@article{c2c492dcd6cc469f9ba9ac1741fde346,
title = "Immunomodulators as an antimicrobial tool",
abstract = "The spectrum of infectious diseases has shifted in the past 50 years to include those caused by microbes that cause disease predominantly in immunocompromised individuals. This phenomenon has underscored the dependence of microbial virulence on the immune status of the host. The limited efficacy of the available antimicrobial armamentarium in immunocompromised individuals, combined with increasing resistance to these agents, has led to an urgent need for new therapies for infectious diseases. Immunomodulation represents a novel approach to antimicrobial therapy that depends on bolstering host immunity, rather than direct antimicrobial activity. Immunomodulators can be divided into those that are specific to pathogens (pathogen-specific) and those that are not specific to pathogens (non-specific). However, to date only a few immunomodulators have been evaluated for their efficacy as antimicrobial tools.",
author = "Pirofski, {Liise anne} and Arturo Casadevall",
year = "2006",
month = "10",
doi = "10.1016/j.mib.2006.08.004",
language = "English (US)",
volume = "9",
pages = "489--495",
journal = "Current Opinion in Microbiology",
issn = "1369-5274",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - Immunomodulators as an antimicrobial tool

AU - Pirofski, Liise anne

AU - Casadevall, Arturo

PY - 2006/10

Y1 - 2006/10

N2 - The spectrum of infectious diseases has shifted in the past 50 years to include those caused by microbes that cause disease predominantly in immunocompromised individuals. This phenomenon has underscored the dependence of microbial virulence on the immune status of the host. The limited efficacy of the available antimicrobial armamentarium in immunocompromised individuals, combined with increasing resistance to these agents, has led to an urgent need for new therapies for infectious diseases. Immunomodulation represents a novel approach to antimicrobial therapy that depends on bolstering host immunity, rather than direct antimicrobial activity. Immunomodulators can be divided into those that are specific to pathogens (pathogen-specific) and those that are not specific to pathogens (non-specific). However, to date only a few immunomodulators have been evaluated for their efficacy as antimicrobial tools.

AB - The spectrum of infectious diseases has shifted in the past 50 years to include those caused by microbes that cause disease predominantly in immunocompromised individuals. This phenomenon has underscored the dependence of microbial virulence on the immune status of the host. The limited efficacy of the available antimicrobial armamentarium in immunocompromised individuals, combined with increasing resistance to these agents, has led to an urgent need for new therapies for infectious diseases. Immunomodulation represents a novel approach to antimicrobial therapy that depends on bolstering host immunity, rather than direct antimicrobial activity. Immunomodulators can be divided into those that are specific to pathogens (pathogen-specific) and those that are not specific to pathogens (non-specific). However, to date only a few immunomodulators have been evaluated for their efficacy as antimicrobial tools.

UR - http://www.scopus.com/inward/record.url?scp=33748808683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748808683&partnerID=8YFLogxK

U2 - 10.1016/j.mib.2006.08.004

DO - 10.1016/j.mib.2006.08.004

M3 - Article

C2 - 16931122

AN - SCOPUS:33748808683

VL - 9

SP - 489

EP - 495

JO - Current Opinion in Microbiology

JF - Current Opinion in Microbiology

SN - 1369-5274

IS - 5

ER -